us fda classifies the inspection at- sun pharma's dadra unit as oai, stock under pressure
Published 3 months ago • 3.1K plays • Length 1:15
Download video MP4
Download video MP3
Similar videos
-
1:00
us fda on sun pharma’s dadra unit: failed to clean, maintain, sanitise equipment at apt intervals
-
3:03
sun pharma dadra unit: us fda warning letter shows multiple repeat observations | n18v | cnbc tv18
-
23:34
sun pharma in focus | us fda to re-inspect halol unit | movers & shakers | cnbc tv18
-
1:54
sun pharma slips in trade after receiving a warning letter from the us fda for its dadra facility
-
2:29
us fda finds incomplete lab records for sun pharma's dadra unit
-
20:58
future of alembic pharma, sun pharma, mahindra cie auto & more stock | your stock | cnbc tv18
-
10:57
sun pharma row : dilip shanghvi assured investors of highest level of corporate governance
-
18:51
dilip shanghvi - sun pharma
-
2:36
u.s. fda issues warning letter to sun pharma, questions manufacturing practices at halol facility
-
1:32
us fda finds incomplete lab records for sun pharma's dadra unit
-
1:18
us fda records 11 observations for sun pharma’s dadra facility
-
2:38
relief for sun pharma: us fda clears sun pharma's dadra unit
-
1:55
sun pharma mohali unit: u.s. fda flags compliance concerns | halftime report | cnbc-tv18
-
1:38
sp tulsian on sun pharma stock, as us fda begins suprise inspection of mohali unit | cnbc tv18
-
2:16
sun pharma's halol facility receives u.s. fda warning letter | business lunch | cnbc-tv18
-
2:15
fertiliser, metal, banking stocks gained while sun pharma, autos were under pressure | cnbc tv18
-
23:49
us fda issues 6 observation on sun pharma | halftime report | cnbc-tv18
-
1:09
u.s fda woes for sun pharma, gets 6 observations for mohali plant | business lunch | cnbc-tv18
-
1:47
sun pharma q4 preview: strong growth in specialty biz likely to boost q4 performance | cnbc tv18
-
2:46
global pharma recalls eye drops from us market after usfda, us cdc issue warning | cnbc-tv18
-
1:59
jubilant lifes’ 2 units inspected by us fda without any observations
-
3:16
decoding the highs & lows of pharma stocks in 2022 | business lunch | cnbc-tv18
Clip.africa.com - Privacy-policy